Global Next-Generation Tissue Biomarkers Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Next-Generation Tissue Biomarkers Market was valued at $3.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 12.7% CAGR, to an estimated market size of $5.5 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The Next-Generation Tissue Biomarkers market encompasses advanced diagnostic tools, technologies, and assays – specifically Next-Generation Sequencing (NGS), genomic-based assays, and digital pathology – used to identify and analyze biological markers within tissue samples. This market excludes traditional blood-based liquid biopsies unless used in conjunction with tissue analysis, focusing instead on personalized medicine and precision oncology through the study of genetic, proteomic, and transcriptomic indicators in solid tissues.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Next-Generation Tissue Biomarkers Market in the period 2025-30:
- The shift toward personalized medicine is driving demand for patient-specific genetic data to customize treatment plans.
- Integration of artificial intelligence (AI) within digital pathology is enhancing the speed and accuracy of tissue analysis.
- The rapid adoption of Next-Generation Sequencing (NGS) allows for the simultaneous analysis of multiple cancer-related genes in a single workflow.
- Increased development of companion diagnostics (CDx) is facilitating targeted therapy selection and accelerating regulatory approvals for new drugs.
- Rising demand for multiplex biomarker assays enables the detection of several indicators within a single tissue sample, preserving limited specimen volume.
- Expansion of cloud-based data platforms is improving the management and interpretation of complex multi-omics datasets across global research networks.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Next-Generation Sequencing (NGS)
- Immunohistochemistry (IHC) & PCR
- Digital Pathology & AI
- Other (Proteomics & Mass Spectrometry)